EDITORIAL
Published on 19 Oct 2022
Editorial: The effect of anti-cancer drug therapies in the treatment of lung cancer
doi 10.3389/fonc.2022.1035245
- 801 views
- Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- The Effect of Anti-Cancer Drug Therapies in the Treatment of Lung Cancer
The Effect of Anti-Cancer Drug Therapies in the Treatment of Lung Cancer
30k
Total downloads
85k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
CASE REPORT
Published on 07 Jul 2022
Case Report: Heterogeneity of Resistance Mechanisms in Different Lesions Co-Mediate Acquired Resistance to First-Line Icotinib in EGFR Mutant Non-Small Cell Lung Cancer
doi 10.3389/fmed.2022.906364
- 1,673 views
- 2 citations
ORIGINAL RESEARCH
Published on 28 Apr 2022
Osimertinib as Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: A Case Series
doi 10.3389/fphar.2022.912153
- 3,054 views
- 9 citations
ORIGINAL RESEARCH
Published on 22 Apr 2022
Immortal Time Bias-Corrected Effectiveness of Traditional Chinese Medicine in Non-Small Cell Lung Cancer (C-EVID): A Prospective Cohort Study
doi 10.3389/fonc.2022.845613
- 2,465 views
- 7 citations
ORIGINAL RESEARCH
Published on 13 Apr 2022
GPX4 Plays a Crucial Role in Fuzheng Kang’ai Decoction-Induced Non-Small Cell Lung Cancer Cell Ferroptosis
doi 10.3389/fphar.2022.851680
- 3,155 views
- 24 citations
CASE REPORT
Published on 10 Mar 2022
Case Report: Hepatic Sarcoid-Like Reaction Associated With Checkpoint Inhibition in a NSCLC Patient and a Literature Review
doi 10.3389/fonc.2022.824308
- 1,872 views
- 7 citations
CASE REPORT
Published on 04 Mar 2022
Immunotherapy for a POLE Mutation Advanced Non-Small-Cell Lung Cancer Patient
doi 10.3389/fphar.2022.817265
- 2,689 views
- 7 citations
ORIGINAL RESEARCH
Published on 18 Feb 2022
Hedgehog Suppresses Paclitaxel Sensitivity by Regulating Akt-Mediated Phosphorylation of Bax in EGFR Wild-Type Non-Small Cell Lung Cancer Cells
doi 10.3389/fphar.2022.815308
- 1,736 views
- 8 citations
ORIGINAL RESEARCH
Published on 31 Jan 2022
Berberine Inhibits FOXM1 Dependent Transcriptional Regulation of POLE2 and Interferes With the Survival of Lung Adenocarcinoma
doi 10.3389/fphar.2021.775514
- 1,782 views
- 10 citations
ORIGINAL RESEARCH
Published on 19 Jan 2022
FGFC1 Selectively Inhibits Erlotinib-Resistant Non-Small Cell Lung Cancer via Elevation of ROS Mediated by the EGFR/PI3K/Akt/mTOR Pathway
doi 10.3389/fphar.2021.764699
- 2,971 views
- 15 citations
CASE REPORT
Published on 05 Jan 2022
Case Report: A Novel Non-Reciprocal ALK Fusion: ALK-GCA and EML4-ALK Were Identified in Lung Adenocarcinoma, Which May Respond to Alectinib Adjuvant-Targeted Therapy
doi 10.3389/fonc.2021.782682
- 1,824 views
- 5 citations
ORIGINAL RESEARCH
Published on 03 Jan 2022
Osimertinib Rechallenge With Bevacizumab vs. Chemotherapy Plus Bevacizumab in EGFR-Mutant NSCLC Patients With Osimertinib Resistance
doi 10.3389/fphar.2021.746707
- 4,119 views
- 14 citations
Published in
Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Medicine
- 3.1 impact factor
- 5.1 citescore
Frontiers in Pharmacology
- 4.4 impact factor
- 7.8 citescore
Impact
- 85kTopic views
- 54kArticle views
- 30kArticle downloads